Gemini Space Station, Inc. filed a Form 8-K with the Securities and Exchange Commission on October 14, 2026, announcing the filing of a prospectus supplement. This supplement relates to the Company’s existing registration statement on Form S-3 (Registration No. 333-299242). The filing is intended to register the potential resale of up to 7,142,857 shares of the Company’s Class A common stock, which have a par value of $0.001 per share.
The registration statement does not obligate the selling investor to sell any of the shares. The Company’s principal executive offices are located at 600 Third Avenue, 2nd Floor, New York, NY 10016. The Company’s Class A common stock trades under the ticker symbol GEMI on The Nasdaq Stock Market LLC.
The filing includes an opinion from the law firm Brownstein Hyatt Farber Schreck, LLP regarding the validity of the shares covered by the prospectus supplement under Nevada law. This legal opinion is attached as Exhibit 5.1 to the Form 8-K and is incorporated by reference. Exhibit 23.1 contains the consent of Brownstein Hyatt Farber Schreck, LLP, which is included within the legal opinion.
